Two common polymorphic variants of OATP4A1 as potential risk factors for colorectal cancer.
colorectal cancer
colorectal cancer risk
polymorphic variants
rs1047099
rs34419428
single-nucleotide polymorphism
solute carrier
solute carrier organic anion transporter family member 4A1
Journal
Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
24
01
2020
accepted:
03
08
2020
entrez:
30
9
2020
pubmed:
1
10
2020
medline:
1
10
2020
Statut:
ppublish
Résumé
Genetic variations in the organic-anion-transporting polypeptide (OATP)-encoding solute carrier of organic anions (
Identifiants
pubmed: 32994815
doi: 10.3892/ol.2020.12115
pii: OL-0-0-12115
pmc: PMC7509609
doi:
Types de publication
Journal Article
Langues
eng
Pagination
252Informations de copyright
Copyright: © Buxhofer-Ausch et al.
Références
Biochim Biophys Acta. 2003 Jan 10;1609(1):1-18
pubmed: 12507753
Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:633-47
pubmed: 12432949
Protein Expr Purif. 2008 Feb;57(2):163-71
pubmed: 18024077
Nat Rev Genet. 2008 Jun;9(6):477-85
pubmed: 18427557
BMC Cancer. 2017 Dec 28;17(1):901
pubmed: 29282011
Sci Rep. 2018 Feb 8;8(1):2630
pubmed: 29422623
Biochim Biophys Acta. 2015 Feb;1848(2):477-87
pubmed: 25445676
Pharmacogenomics J. 2014 Feb;14(1):48-53
pubmed: 23545897
Cancer. 2015 Sep 15;121(18):3261-71
pubmed: 26036212
Oncol Lett. 2019 Dec;18(6):5673-5680
pubmed: 31788039
BMC Gastroenterol. 2012 Jun 26;12:78
pubmed: 22734885
Biomed Res Int. 2013;2013:286902
pubmed: 24073397
Mol Pharm. 2015 Dec 7;12(12):4259-69
pubmed: 26474710
AAPS J. 2015 May;17(3):535-45
pubmed: 25735612
Br J Clin Pharmacol. 2017 Jun;83(6):1176-1184
pubmed: 27936281
Curr Top Membr. 2014;73:205-32
pubmed: 24745984
Annu Rev Pharmacol Toxicol. 2012;52:135-51
pubmed: 21854228
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
J Biol Chem. 2002 Dec 13;277(50):47980-90
pubmed: 12374800
Biochem Pharmacol. 2015 Dec 15;98(4):649-58
pubmed: 26415544
Curr Drug Metab. 2011 Feb;12(2):139-53
pubmed: 21395542
Bioinformatics. 2001 Sep;17(9):849-50
pubmed: 11590105
Handb Exp Pharmacol. 2011;(201):1-28
pubmed: 21103967
Pharmacol Res. 2019 Jan;139:550-559
pubmed: 30359687
CSH Protoc. 2008 May 01;2008:pdb.prot4986
pubmed: 21356829
Pharm Res. 2019 May 15;36(7):101
pubmed: 31093828
Appl Immunohistochem Mol Morphol. 2019 Mar;27(3):185-194
pubmed: 29734253
Int J Mol Sci. 2018 Mar 14;19(3):
pubmed: 29538325
Biomed Res Int. 2015;2015:569071
pubmed: 26579535
Expert Opin Drug Metab Toxicol. 2017 Apr;13(4):409-424
pubmed: 27783531
Br J Pharmacol. 2009 Oct;158(3):693-705
pubmed: 19785645
Mob DNA. 2011 Mar 03;2(1):5
pubmed: 21371313
Tumour Biol. 2017 Mar;39(3):1010428317691176
pubmed: 28349822
World J Clin Cases. 2018 Nov 6;6(13):577-588
pubmed: 30430113
J Membr Biol. 2005 Dec;208(3):213-27
pubmed: 16648940
Biochemistry. 2008 Sep 2;47(35):9090-7
pubmed: 18690707
Biomed Pharmacother. 2015 Aug;74:233-42
pubmed: 26349991
Br J Cancer. 2015 Mar 3;112(5):857-65
pubmed: 25611302
Drug Metab Lett. 2007 Jan;1(1):23-30
pubmed: 19356014
Br J Pharmacol. 2012 Mar;165(5):1260-87
pubmed: 22013971
J Drug Deliv. 2013;2013:863539
pubmed: 23431456
Nucleic Acids Res. 2020 Jan 8;48(D1):D941-D947
pubmed: 31584097
Cancer Res. 2008 Dec 15;68(24):10315-23
pubmed: 19074900
Pharmacogenomics. 2018 May;19(7):613-619
pubmed: 29701127
Bioinformatics. 2015 Nov 1;31(21):3555-7
pubmed: 26139635
J Cancer Res Clin Oncol. 2017 Aug;143(8):1437-1447
pubmed: 28378090
Front Pharmacol. 2017 Mar 07;8:103
pubmed: 28326039
Mol Aspects Med. 2013 Apr-Jun;34(2-3):396-412
pubmed: 23506880
Methods Mol Biol. 2014;1175:91-120
pubmed: 25150868